APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 68 filers reported holding APTOSE BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $352,000 | +10.3% | 550,000 | 0.0% | 0.04% | -27.4% |
| Q4 2022 | $319,000 | -10.6% | 550,000 | -8.3% | 0.06% | -39.2% |
| Q3 2022 | $357,000 | -31.2% | 600,000 | -14.3% | 0.10% | -39.3% |
| Q2 2022 | $519,000 | -30.6% | 700,010 | +27.3% | 0.17% | -28.5% |
| Q1 2022 | $748,000 | +0.7% | 550,000 | 0.0% | 0.24% | +2.2% |
| Q4 2021 | $743,000 | +405.4% | 550,000 | +713.6% | 0.23% | +283.3% |
| Q3 2021 | $147,000 | -89.5% | 67,600 | -83.9% | 0.06% | -89.7% |
| Q2 2021 | $1,395,000 | -46.9% | 420,161 | -4.5% | 0.58% | -47.1% |
| Q1 2021 | $2,629,000 | -16.1% | 440,000 | -38.5% | 1.10% | -30.6% |
| Q4 2020 | $3,132,000 | -23.5% | 715,000 | +4.7% | 1.58% | -32.4% |
| Q3 2020 | $4,096,000 | +60.3% | 682,579 | +68.5% | 2.34% | +36.7% |
| Q2 2020 | $2,556,000 | +36.5% | 405,000 | -23.8% | 1.71% | -31.7% |
| Q1 2020 | $1,873,000 | +8.1% | 531,200 | +73.8% | 2.50% | +859.0% |
| Q4 2019 | $1,732,000 | – | 305,600 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 690,000 | $4,123,000 | 3.63% |
| DRW Securities, LLC | 7,976,176 | $47,658,000 | 1.89% |
| Ally Bridge Group (NY) LLC | 1,409,150 | $8,420,000 | 1.61% |
| Nantahala Capital Management | 7,738,892 | $46,240,000 | 1.35% |
| PRECEPT MANAGEMENT LLC | 330,766 | $1,976,000 | 1.35% |
| First Light Asset Management, LLC | 3,102,788 | $18,539,000 | 1.23% |
| Voss Capital, LLC | 440,000 | $2,629,000 | 1.10% |
| VR Adviser, LLC | 1,605,400 | $9,592,000 | 1.04% |
| Endurant Capital Management LP | 517,472 | $3,092,000 | 0.81% |
| Opaleye Management Inc. | 871,800 | $5,209,000 | 0.76% |